Scott E Wolkenberg - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Scott E Wolkenberg

Showing results (31-40 of 33) with videos related to

Pageof 4

Sort By:

You have reached the last page of results.This site can display upto 33 results.

Bioorganic & Medicinal Chemistry Letters|January 30, 2017

Discovery of MK-1832, a Kv1.5 inhibitor with improved selectivity and pharmacokineticsScott E Wolkenberg, M Brad Nolt, Mark T Bilodeau, et al.

ACS Chemical Neuroscience|August 4, 2012

Characterization of non-nitrocatechol pan and isoform specific catechol-O-methyltransferase inhibitors and substratesRonald G Robinson, Sean M Smith, Scott E Wolkenberg, et al.

Bioorganic & Medicinal Chemistry Letters|May 4, 2017

Benzoxazolinone aryl sulfonamides as potent, selective Na<sub>v</sub>1.7 inhibitors with in vivo efficacy in a preclinical pain modelJoseph E Pero, Michael A Rossi, Hannah D G F Lehman, et al.

Pageof 4

Search research articles

Showing results (31-40 of 33) with videos related to

Sort By:

Pageof 4

You have reached the last page of results.This site can display upto 33 results.

Bioorganic & Medicinal Chemistry Letters|January 30, 2017

Discovery of MK-1832, a Kv1.5 inhibitor with improved selectivity and pharmacokineticsScott E Wolkenberg, M Brad Nolt, Mark T Bilodeau, et al.

ACS Chemical Neuroscience|August 4, 2012

Characterization of non-nitrocatechol pan and isoform specific catechol-O-methyltransferase inhibitors and substratesRonald G Robinson, Sean M Smith, Scott E Wolkenberg, et al.

Bioorganic & Medicinal Chemistry Letters|May 4, 2017

Benzoxazolinone aryl sulfonamides as potent, selective Na<sub>v</sub>1.7 inhibitors with in vivo efficacy in a preclinical pain modelJoseph E Pero, Michael A Rossi, Hannah D G F Lehman, et al.

Pageof 4